Etoposide Recruiting Phase 4 Trials for ALK-Positive Anaplastic Large Cell Lymphoma Treatment

IndicationsStatusPurposePhase
RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03707847Crizotinib Combined With Etoposide Capsule Followed by Auto-HSCT for Relapsed and Refractory ALK+ ALCL